FMR CORP 13D/13G Filings for Immunovant, Inc. (IMVT)

FMR CORP 13D and 13G filings for Immunovant, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-03-07
10:01 am
Purchase		 2025-02-28 13G Immunovant, Inc.
IMVT		 FMR CORP 17,078,093
10.100%		 4,540,522increase
(+36.22%)		 Filing
2024-11-12
10:32 am
Purchase		 2024-11-08 13G Immunovant, Inc.
IMVT		 FMR CORP 12,537,571
8.565%		 4,661,749increase
(+59.19%)		 Filing
2024-02-09
09:16 am
Purchase		 2024-02-08 13G Immunovant, Inc.
IMVT		 FMR CORP 7,875,822
5.444%		 7,875,822increase
(New Position)		 Filing